Skip to content

ZIPS Study - Zip Incision aPproximation vs. Suture

A Prospective, Non-blinded, Randomized Controlled Post-market Study Designed to Compare the Use of the Zip Surgical Skin Closure Device Versus Conventional Sutures for Skin Closure in Subjects Who Undergo a CIED Procedure.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02213510
Acronym
ZIPS
Enrollment
40
Registered
2014-08-11
Start date
2014-08-31
Completion date
2015-06-30
Last updated
2016-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrhythmia, Wound

Keywords

pacemaker, implantable cardioverter defibrillator, ICD, surgical wound closure, sutures, Zipline, Zips, CIED, cardiovascular implantable electronic devices, arrhythmia

Brief summary

ZipLine Medical, Inc. has developed a novel, non-invasive skin closure device called Zip Surgical Skin Closure to replace sutures, staples and glue for closure of the skin layer for surgical incisions or laceration repair. The study will be comparing the Zip Surgical Skin Closure to standard sutures in patients undergoing cardiovascular implantable electronic device (CIED) procedures on outcomes including closure time, cosmetic appearance of resulting scar, and overall cosmetic appearance of scar. The study will be following participants for 3 months following CIED procedure.

Detailed description

ZipLine Medical, Inc. has developed a novel, non-invasive skin closure device called Zip Surgical Skin Closure to replace sutures, staples and glue for closure of the skin layer for surgical incisions or laceration repair. The device is designed to provide closure speed superior to sutures, while resulting in a suture-like cosmetic outcome.The ZIPS study is a randomized, clinical trial comparing outcomes of procedures that use the Zip Surgical Skin Closure device with the outcomes of procedures that use stitches. The Zip Surgical Skin Closure is not an investigational device and is currently used in hospital across the United States. The Zip Surgical Skin Closure is a non-invasive (in other words, does not pierce the skin or enter into the wound) device to hold skin closed while healing can occur. It adheres to the skin close to the incision and uses adjustable straps to hold the incision closed. It is typically worn on the skin for 7-14 days and is removed by peeling from the skin. Patients will be randomized to either Zip Surgical Skin Closure or sutures, in addition to dissolvable sutures for the deeper layers, for surgical procedures for cardiovascular implantable electronic devices (CIED) i.e. pacemakers or defibrillators. Both of these closure techniques are considered standard of care at this facility and are not themselves experimental. However, the goal of this experimental study is to see if there are any significant differences between the two closure methods, in a controlled study environment. Since the Zip Surgical Skin Closure device is relatively new to the market, there is a limited amount of information available describing the experience of patients and doctors using the device. In this study, the investigators will be looking to compare the Zip Surgical Skin Closure and stitches methods for the time necessary for the surgeon to close the incision, cosmetic appearance of the resulting scar, and satisfaction of you and your surgeon. The investigators will also be monitoring both study groups for occurrence of any adverse (unfavorable) events. Patients will be followed for a total of 3 months for this study. All study visits align with standard of care follow up for post-implantation of CIED. Non-identifiable pictures will be obtained of the scar during follow up and both patients and surgeons will complete questionnaires indicating their experience and satisfaction with the either skin closure method.

Interventions

The Zip Surgical Skin Closure device is a single use, sterile medical device that replaces sutures, staples, and glue for closure of the skin layer for surgical incisions or laceration repair. The device will applied by the surgeon at the end of the CIED procedure and be worn until the two week post-operative wound check.

DEVICEStandard Suture Closure

The surgeon will perform standard suture closure for the skin layer following CIED procedure.

Sponsors

ZipLine Medical Inc.
CollaboratorINDUSTRY
University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients 18 years of age and older; 2. Patients requiring suture closure for epidermal closure (after placement of cardiac implantable electronic devices; including de novo and re implant generator changes); 3. Patients willing and able to complete study protocol 4. Life expectancy greater than 1 year

Exclusion criteria

1. Known bleeding disorder not caused by medication; 2. Known personal or family history of keloid formation or scar hypertrophy; 3. Known allergy or hypersensitivity to non-latex skin adhesives; 4. Atrophic skin deemed clinically prone to blistering; 5. Any skin disorder affecting wound healing; 6. Any other condition that in the opinion of the investigator would make a particular subject unsuitable for this study. 7. Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Overall Closure Time2 weeksDuration of time starting when suture needle (control) or Zip device touches the skin until final suture knot is cut or Zip device application is complete (e.g., top liner is removed.)
Wound Healing as Determined by the CVAS (Cosmetic Visual Analogue Scale)3 MonthsBased on photographs taken of scars taken at 3 months following CIED procedure. The CVAS scale is measured from 0mm (representing best scar) to 100 mm (representing worst scar).

Secondary

MeasureTime frameDescription
Surgeon Satisfaction With Scar3 monthsAt 3 months post-procedure, the surgeon evaluated their satisfaction on a scale from 1 to 5, 5 being the least favorable. Please note that only 18 patients were evaluated (of 19) in the Standard Suture Closure due to one patient withdrawing from the trial.
Patient Comfort2 weeksAt 2 weeks post-procedure, patient comfort was evaluated with a scale 1 (most favorable) to 5 (least favorable).
Surgeon Wound Evaluation Scale (WES)2 weeksAt 2 weeks post-procedure, the Wound Evaluation Scale was measured. The scale is based from 0 (representing normal skin) to 100 (representing a poor scar).
Patient Rating of Scar3 monthsAt 3 months post-procedure, patients were asked to rate their scar. Scale was measured from 0 (best scar) - 10 (worst scar) Please note that only 18 patients were evaluated (of 19) in the Standard Suture Closure due to one patient withdrawing from the trial.
Patient Incision Pain1 day (discharge)At the discharge visit, patients evaluated their level of pain at the incision site based on a scale 1 (least pain) through 10 (worst pain).
Patient Satisfaction With Scar3 monthsPatient will complete questionnaires that includes assessments of the following: 1. Pain 2. Closure Method Comfort 3. Closure Method Satisfaction 4. Scar Satisfaction Scar Satisfaction was measured on a scale from 1 (most satisfied) to 5 (least satisfied) Please note that only 18 patients were evaluated (of 19) in the Standard Suture Closure due to one patient withdrawing from the trial.
Surgeon Evaluation Based on the Wound Evaluation Scale (WES)3 MonthsThe surgeon will complete an assessment of the following: 1. Closure Method Satisfaction 2. Scar Satisfaction 3. Wound Healing as judged by Wound Evaluation Scale Scale rated on 1 (least favorable) to 6 (most favorable) Please note that only 18 patients were evaluated (of 19) in the Standard Suture Closure due to one patient withdrawing from the trial.

Countries

United States

Participant flow

Participants by arm

ArmCount
Zip Surgical Skin Closure Device
The Zip Surgical Skin Closure device is a single use, sterile medical device that replaces sutures, staples, and glue for closure of the skin layer for surgical incisions or laceration repair. The device will applied by the surgeon at the end of the CIED procedure and be worn until the two week post-operative wound check. Zip Surgical Skin Closure Device: The Zip Surgical Skin Closure device is a single use, sterile medical device that replaces sutures, staples, and glue for closure of the skin layer for surgical incisions or laceration repair. The device will applied by the surgeon at the end of the CIED procedure and be worn until the two week post-operative wound check.
21
Standard Suture Closure
The surgeon will perform standard suture closure for the skin layer following CIED procedure. Standard Suture Closure: The surgeon will perform standard suture closure for the skin layer following CIED procedure.
19
Total40

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath01
Overall StudyLost to Follow-up10

Baseline characteristics

CharacteristicTotalStandard Suture ClosureZip Surgical Skin Closure Device
Age, Continuous70 years70 years71 years
Fitzpatrick Skin Scale
1 - Always burns, never tans
2 participants0 participants2 participants
Fitzpatrick Skin Scale
2 - Usually burns, tans with difficulty
2 participants1 participants1 participants
Fitzpatrick Skin Scale
3 - Somtimes mild burn, gradually tans
13 participants6 participants7 participants
Fitzpatrick Skin Scale
4 - Rarely burns, tans with ease
13 participants7 participants6 participants
Fitzpatrick Skin Scale
5 - Very rarely burns, tans very easily
7 participants3 participants4 participants
Fitzpatrick Skin Scale
6 - Never burns, tans very easily
3 participants2 participants1 participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
2 Participants1 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
36 Participants17 Participants19 Participants
Region of Enrollment
United States
40 participants19 participants21 participants
Sex: Female, Male
Female
15 Participants7 Participants8 Participants
Sex: Female, Male
Male
25 Participants12 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 210 / 19
serious
Total, serious adverse events
0 / 210 / 19

Outcome results

Primary

Overall Closure Time

Duration of time starting when suture needle (control) or Zip device touches the skin until final suture knot is cut or Zip device application is complete (e.g., top liner is removed.)

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Zip Surgical Skin Closure DeviceOverall Closure Time78 secondsStandard Deviation 30.36
Standard Suture ClosureOverall Closure Time216 secondsStandard Deviation 93.71
p-value: <0.001t-test, 2 sided
Primary

Wound Healing as Determined by the CVAS (Cosmetic Visual Analogue Scale)

Based on photographs taken of scars taken at 3 months following CIED procedure. The CVAS scale is measured from 0mm (representing best scar) to 100 mm (representing worst scar).

Time frame: 3 Months

Population: Please note that only 18 patients were evaluated (of 19) in the Standard Suture Closure due to one patient withdrawing from the trial.

ArmMeasureValue (MEAN)Dispersion
Zip Surgical Skin Closure DeviceWound Healing as Determined by the CVAS (Cosmetic Visual Analogue Scale)35.8 mmStandard Deviation 40.6
Standard Suture ClosureWound Healing as Determined by the CVAS (Cosmetic Visual Analogue Scale)40.6 mmStandard Deviation 21.7
p-value: 0.655t-test, 2 sided
Secondary

Patient Comfort

At 2 weeks post-procedure, patient comfort was evaluated with a scale 1 (most favorable) to 5 (least favorable).

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Zip Surgical Skin Closure DevicePatient Comfort1.77 units on a scaleStandard Deviation 1.15
Standard Suture ClosurePatient Comfort1.94 units on a scaleStandard Deviation 1.16
p-value: 0.646t-test, 2 sided
Secondary

Patient Incision Pain

At the discharge visit, patients evaluated their level of pain at the incision site based on a scale 1 (least pain) through 10 (worst pain).

Time frame: 1 day (discharge)

ArmMeasureValue (MEAN)Dispersion
Zip Surgical Skin Closure DevicePatient Incision Pain1.77 units on a scaleStandard Deviation 2.48
Standard Suture ClosurePatient Incision Pain2.15 units on a scaleStandard Deviation 1.83
p-value: 0.588t-test, 2 sided
Secondary

Patient Incision Pain

Incision pain experienced by the patient was evaluated at 3 months post-procedure. This was evaluated on a scale of 0 (least pain) to 10 (worst pain).

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Zip Surgical Skin Closure DevicePatient Incision Pain0.27 units on a scaleStandard Deviation 0.41
Standard Suture ClosurePatient Incision Pain0.27 units on a scaleStandard Deviation 0.73
p-value: 1t-test, 2 sided
Secondary

Patient Incision Pain

At 2 week post-procedure, incision pain was evaluated on a scale 0 to 10 (worst pain).

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Zip Surgical Skin Closure DevicePatient Incision Pain0.64 units on a scaleStandard Deviation 0.92
Standard Suture ClosurePatient Incision Pain0.71 units on a scaleStandard Deviation 1.41
p-value: 0.858t-test, 2 sided
Secondary

Patient Rating of Scar

At 3 months post-procedure, patients were asked to rate their scar. Scale was measured from 0 (best scar) - 10 (worst scar) Please note that only 18 patients were evaluated (of 19) in the Standard Suture Closure due to one patient withdrawing from the trial.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Zip Surgical Skin Closure DevicePatient Rating of Scar0.87 units on a scaleStandard Deviation 0.76
Standard Suture ClosurePatient Rating of Scar1.04 units on a scaleStandard Deviation 1.39
p-value: 0.651t-test, 2 sided
Secondary

Patient Satisfaction With Scar

Patient will complete questionnaires that includes assessments of the following: 1. Pain 2. Closure Method Comfort 3. Closure Method Satisfaction 4. Scar Satisfaction Scar Satisfaction was measured on a scale from 1 (most satisfied) to 5 (least satisfied) Please note that only 18 patients were evaluated (of 19) in the Standard Suture Closure due to one patient withdrawing from the trial.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Zip Surgical Skin Closure DevicePatient Satisfaction With Scar1.32 units on a scaleStandard Deviation 0.48
Standard Suture ClosurePatient Satisfaction With Scar1.22 units on a scaleStandard Deviation 0.43
p-value: 0.51t-test, 2 sided
Secondary

Surgeon Evaluation Based on the Wound Evaluation Scale (WES)

The surgeon will complete an assessment of the following: 1. Closure Method Satisfaction 2. Scar Satisfaction 3. Wound Healing as judged by Wound Evaluation Scale Scale rated on 1 (least favorable) to 6 (most favorable) Please note that only 18 patients were evaluated (of 19) in the Standard Suture Closure due to one patient withdrawing from the trial.

Time frame: 3 Months

ArmMeasureValue (MEAN)Dispersion
Zip Surgical Skin Closure DeviceSurgeon Evaluation Based on the Wound Evaluation Scale (WES)6 units on a scaleStandard Deviation 0
Standard Suture ClosureSurgeon Evaluation Based on the Wound Evaluation Scale (WES)6 units on a scaleStandard Deviation 0
p-value: 1t-test, 2 sided
Secondary

Surgeon Satisfaction With Scar

At 3 months post-procedure, the surgeon evaluated their satisfaction on a scale from 1 to 5, 5 being the least favorable. Please note that only 18 patients were evaluated (of 19) in the Standard Suture Closure due to one patient withdrawing from the trial.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Zip Surgical Skin Closure DeviceSurgeon Satisfaction With Scar1 units on a scaleStandard Deviation 0
Standard Suture ClosureSurgeon Satisfaction With Scar1.06 units on a scaleStandard Deviation 0.24
p-value: 0.462t-test, 2 sided
Secondary

Surgeon Wound Evaluation Scale (WES)

At 2 weeks post-procedure, the Wound Evaluation Scale was measured. The scale is based from 0 (representing normal skin) to 100 (representing a poor scar).

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Zip Surgical Skin Closure DeviceSurgeon Wound Evaluation Scale (WES)5.82 units on a scaleStandard Deviation 0.5
Standard Suture ClosureSurgeon Wound Evaluation Scale (WES)5.78 units on a scaleStandard Deviation 0.55
p-value: 0.811t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026